Michael Satlin

19PUBLICATIONS
59CO-AUTHORS
Environmental epidemiologyMedical infection agents (incl. prions)PharmacogenomicsVictimsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 26, 2026
Colonization with extended-spectrum and AmpC β-lactamase-producing Enterobacterales and bacteremia risk in patients with acute leukemia who receive induction chemotherapy without fluoroquinolone prophylaxis.

|May 15, 2026
Genomic and Clinical Features Associated with Reduced Susceptibility to Cefiderocol and Cross-resistance to β-lactam/β-lactamase Inhibitors in a Global Cohort of Pseudomonas aeruginosa.

|May 15, 2026
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study.

|Mar 08, 2026
Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections.

Natalie A Mackow, Wanying Shao, Lizhao Ge

|Jan 08, 2026
Fulminant and fatal <i>Trypanosoma cruzi</i> reactivation in a patient with lymphoma.

Georgi Lukose, Anna Mertelsmann, Rebecca M Marrero Rolon

|Jan 08, 2026
Impact of Rapid Molecular Diagnostic Testing on Outcomes of Patients With Vancomycin-Resistant Enterococcal Bacteremia.

Michael R Hovan, Michael J Burkitt, Sierra A Derti

Pageof 4

Frequent Collaborators

4 joint publications

Liang Chen

2 joint publications

Robin Patel

2 joint publications

Cesar A Arias

2 joint publications

Vance G Fowler